Exocytosis inhibitors are compounds or proteins that disrupt the exocytosis process. They can act at various stages of vesicle fusion, such as vesicle docking, priming, or membrane fusion. These inhibitors are valuable tools for studying the mechanisms of exocytosis and identifying potential therapeutic targets for diseases involving exocytosis dysregulation, such as neurodegenerative disorders and diabetes.
